Brent Lalomia

Brent Lalomia

Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial OperationsatCONMED· In proxies 2024–2025

Pay in FY2025

Brent Lalomia was paid $1.7M in FY2025 (Dec).

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each CONMED proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CONMEDPublic company · 2 yr
    • Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations2024 – Present · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?